1 . Dürr HR, Hett M, Klein A, Rakete S, Holzapfel BM, Lahr C. Highly Elevated Metal Ion Levels After Tumor Resections and Reconstruction With Megaprostheses Around the Knee. Clin Orthop Relat Res. 2025 Apr 23. doi: 10.1097/CORR.0000000000003515. Epub ahead of print. PMID: 40279194.

2. Burkhard-Meier A, Rechenauer VV, Berclaz LM, Jurinovic V, Albertsmeier M, Dürr HR, Güler SE, Hoberger M, Klein A, Knösel T, Kunz WG, Schmidt-Hegemann NS, Von Bergwelt-Baildon M, Lindner LH, Di Gioia D. Maintenance treatment with trofosfamide in patients with advanced soft tissue sarcoma - a retrospective single-centre analysis. Acta Oncol. 2025 Jan 15;64:56-62.

3. Erber B, Geßl A, Reidler P, Dürr HR, Klein A, Seidensticker M, Wildgruber M, Ricke J, Sabel B. Impact of reactive sclerosis on outcome of MR-HIFU for osteoid osteomas. Eur J Radiol. 2025 Feb;183:111902. doi: 10.1016/j.ejrad.2024.111902. Epub 2024 Dec 26. PMID: 39753004.

4. Burkhard-Meier A, Rechenauer VV, Jurinovic V, Albertsmeier M, Hoberger M, Dürr HR, Klein A, Knösel T, Kunz WG, Mock A, Pusztai A, Völkl M, von Bergwelt-Baildon M, Lindner LH, Di Gioia D, Berclaz LM. First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. J Cancer Res Clin Oncol. 2025 Apr 26;151(4):150. doi: 10.1007/s00432-025-06208-8. PMID: 40285941; PMCID: PMC12033179.

5. Berclaz LM, Di Gioia D, Völkl M, Jurinovic V, Klein A, Dürr HR, Knösel T, Teodorescu B, Enßle S, Rippl M, von Bergwelt-Baildon M, Kunz WG, Lindner LH, Burkhard-Meier A. The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcoma. BMC Cancer. 2025 Apr 11;25(1):671. doi: 10.1186/s12885-025-14050-x. PMID: 40217461; PMCID: PMC11992814.

6. Gassert FG, Lang D, Hesse N, Dürr HR, Klein A, Kohll L, Hinterwimmer F, Luitjens J, Weissinger S, Peeken JC, Mogler C, Knebel C, Bartzsch S, Gassert FT, Gersing AS. A deep learning model for classification of chondroid tumors on CT images. BMC Cancer. 2025 Mar 28;25(1):561. doi: 10.1186/s12885-025-13951-1. PMID: 40155859; PMCID: PMC11951610.

7. Berclaz LM, Di Gioia D, Jurinovic V, Völkl M, Güler SE, Albertsmeier M, Klein A, Dürr HR, Mansoorian S, Knösel T, Kunz WG, von Bergwelt-Baildon M, Lindner LH, Burkhard-Meier A. LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatment. BMC Cancer. 2025 Mar 18;25(1):496. doi: 10.1186/s12885-025-13889-4. PMID: 40102864; PMCID: PMC11916319.

8. Berclaz LM, Jurinovic V, Burkhard-Meier A, Abdel-Rahman S, Albertsmeier M, Klein A, Dürr HR, Schmidt-Hegemann NS, Knösel T, Kunz WG, Stutz E, von Bergwelt-Baildon M, Di Gioia D, Lindner LH. Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched Analysis. Cancer Med. 2025 Feb;14(4):e70655. doi: 10.1002/cam4.70655. PMID: 40007213; PMCID: PMC11861570.

9. Klein A, Dürr HR. SOP Pathologische Frakturen der Extremitätenknochen. Orthopädie und Unfallchirurgie up2date 2025; 20(05): 453-458

10. Bode-Lesniewska B, Dürr HR, Wang D, Naghavi A, Montreuil J, Fischer T, Ghert M, Lazarides A, Lindner L, Martin-Broto J, Mazza M, Scanferla R, Studer G, Temple HT, Wunder J, Fuchs B. Rethinking the Prognostic Role of Necrosis in Soft-Tissue Sarcoma: Multidisciplinary Insights from the Sarcoma Academy. Cancers (Basel). 2025 May 26;17(11):1779. doi: 10.3390/cancers17111779. PMID: 40507260; PMCID: PMC12153611.

11. Burkhard-Meier A, Grube M, Jurinovic V, Agaimy A, Albertsmeier M, Berclaz LM, Di Gioia D, Dürr HR, von Eisenhart-Rothe R, Eze C, Fechner K, Fey E, Güler SE, Hecker JS, Hendricks A, Keil F, Klein A, Knebel C, Kovács JR, Kunz WG, Lenze U, Lörsch AM, Lutz M, Meidenbauer N, Mogler C, Schmid S, Schmidt-Hegemann NS, Schneider C, Semrau S, Sienel W, Trepel M, Waldschmidt J, Wiegering A, Lindner LH. Does Size Outweigh Number in Predicting Survival After Pulmonary Metastasectomy for Soft Tissue Sarcoma? Insights from a Retrospective Multicenter Study. Ann Surg Oncol. 2025 Aug;32(8):5948-5956. doi: 10.1245/s10434-025-17450-2. Epub 2025 May 14. PMID: 40369396; PMCID: PMC12222427.

12. Burkhard-Meier A, Rechenauer VV, Jurinovic V, Albertsmeier M, Hoberger M, Dürr HR, Klein A, Knösel T, Kunz WG, Mock A, Pusztai A, Völkl M, von Bergwelt-Baildon M, Lindner LH, Di Gioia D, Berclaz LM. First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. J Cancer Res Clin Oncol. 2025 Apr 26;151(4):150. doi: 10.1007/s00432-025-06208-8. PMID: 40285941; PMCID: PMC12033179.

Hoberger M, Zuber RL, Burkhard-Meier A, Di Gioia D, Jurinovic V, Völkl M, Güler SE, Albertsmeier M, Klein A, Dürr HR, Schmidt-Hegemann NS, Knösel T, Kunz WG, von Bergwelt-Baildon M, Lindner LH, Berclaz LM. Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis. J Cancer Res Clin Oncol. 2026 Jan 8;152(1):34. doi: 10.1007/s00432-025-06410-8. PMID: 41504936; PMCID: PMC12783467.

Nachfolgend die vollständige Liste der Publikationen unseres Schwerpunktes (bitte Bild anklicken).